Cell and Gene Therapy Market Poised for Blockbuster Growth

Published by Alliance for Regenerative Medicine

The cell and gene therapy sector is rapidly expanding, with two blockbuster products already on the market and two more expected by the end of 2025. Analyst consensus forecasts predict that by 2030 there will be 10 blockbusters, alongside more than 15 other therapies each surpassing $500 million in annual sales. This surge reflects how transformative biotechnology translates breakthroughs into sustainable, life-changing treatments while driving exponential market growth from $8.4 billion in 2024 to an estimated $54.4 billion by 2030.

👉 Read the full article: #ReasonsToBelieve in CGT | Turning Breakthroughs into Blockbusters

Disclaimer

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link. SSCTR does not provide medical advice, and the views expressed are for educational purposes only.